Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

235

Participants

Timeline

Start Date

April 28, 2022

Primary Completion Date

April 26, 2024

Study Completion Date

October 30, 2024

Conditions
Sedation
Interventions
DRUG

Isoflurane

Inhaled isoflurane administered by Sedaconda ACD-S

DRUG

Propofol

Intravenous infusion of propofol

Trial Locations (14)

22903

University of Virginia, Charlottesville

30322

Emory University, Atlanta

37232

Vanderbilt University Medical Center, Nashville

44195

The Cleveland Clinic Foundation, Cleveland

45219

University of Cincinnati, Cincinnati

55905

Mayo Clinic, Rochester

60637

University of Chicago, Chicago

75390

University of Texas Southwestern Medical Center, Dallas

77030

Houston Methodist Hospital, Houston

MD Anderson Cancer Center, Houston

80045

University of Colorado Anschutz Medical Campus, Aurora

84111

Intermountain Health Care Health Services, Salt Lake City

02111

Tufts Medical Center, Boston

02115

The Brigham and Women´s Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sedana Medical

INDUSTRY